← all signals · sectors · research
Coherus Oncology, Inc. CHRS
SIC 2836 — Biological Products, (No Diagnostic Substances) · CIK 1512762
This page lists every Interactive Market Data signal that fired on this company across fiscal years, with the calibrated net-of-cost forward-return prediction. Predictions use a triple → pair → singles fallback against our backtest panel (~32K (cik × fy) signal combos, net of execution costs at 5 bps half-spread + ADV-tiered borrow).
FY2025 short
1 signal fired ·
match: singles_avg
| Horizon | Predicted net PnL |
|---|---|
| 20 days | +0.13% |
| 60 days | -9.54% |
| 252 days (1y) | -22.54% |
FY2024 short
2 signals fired ·
match: pair
accruals_quality_low, dso_drift_severe
| Horizon | Predicted net PnL |
|---|---|
| 20 days | +0.16% |
| 60 days | -3.95% |
| 252 days (1y) | -15.32% |
FY2022 short
1 signal fired ·
match: singles_avg
| Horizon | Predicted net PnL |
|---|---|
| 20 days | -2.54% |
| 60 days | -11.34% |
| 252 days (1y) | -24.65% |
FY2021 short
2 signals fired ·
match: pair
fcf_turn_negative, profit_to_loss
| Horizon | Predicted net PnL |
|---|---|
| 20 days | +1.22% |
| 60 days | -2.47% |
| 252 days (1y) | -17.08% |
FY2019 short
2 signals fired ·
match: pair
accruals_quality_low, fcf_turn_positive
| Horizon | Predicted net PnL |
|---|---|
| 20 days | +0.70% |
| 60 days | -3.98% |
| 252 days (1y) | -9.43% |
FY2017 short
1 signal fired ·
match: singles_avg
| Horizon | Predicted net PnL |
|---|---|
| 20 days | +2.05% |
| 60 days | -0.78% |
| 252 days (1y) | -14.91% |
FY2015 short
1 signal fired ·
match: singles_avg
| Horizon | Predicted net PnL |
|---|---|
| 20 days | +2.05% |
| 60 days | -0.78% |
| 252 days (1y) | -14.91% |
Methodology: /methodology · Live JSON: /api/company/1512762/financials